Apitope raises €12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;

@FierceBiotech: Fierce's coverage of the Martin Shkreli saga. More | Follow @FierceBiotech

@JohnCFierce: Sofinnova leads a $30.6M round for Asceneuron's Alzheimer's R&D. Article | Follow @JohnCFierce

@DamianFierce: I wrote about ~ d i s r u p t i o n ~. Article | Follow @DamianFierce

> The autoimmune biotech Apitope raised €12 million in a Series B financing. The round was led by new investor Wales Life Sciences Fund. Current investors Vesalius Biocapital, LRM, PMV and Wyvern also participated with the Wellcome Trust. Brenig Preest, Wales Life Sciences Fund, will join the Apitope board. Release

> Sanofi ($SNY) is one step closer to FDA approval for its answer to Novo Nordisk's ($NVO) blockbuster diabetes drug Victoza, as the agency has accepted its application for GLP-1 treatment lixisenatide. More

> Expanding its focus on immuno-oncology, Merck KGaA has appointed a chief medical officer for its U.S. operation, recruiting Joseph Leveque, a veteran of Bristol-Myers Squibb's ($BMY) cancer operation. News

Medical Device News

@FierceMedDev: Smith & Nephew launches dissolvable nasal dressing for post-op sinus surgery use. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Medtronic launches smartphone app enabling diabetics to remotely monitor their condition. Article | Follow @VarunSaxena2

@EmilyWFierce: Smiths Medical bucks M&A talk amid revived fortunes. More | Follow @EmilyWFierce

> Precision NanoSystems raises $13.4M Series A for diagnostic, therapeutic nanotech platform. More

> JAMA: Computer-aided detection does not help spot breast cancer. Article

Pharma News

@FiercePharma: Shkreli-shaming spills over onto Valeant as Dems call CEO to account for price hikes. More | Follow @FiercePharma

@EricPFierce: ICYMI: Sun Pharma unit Mutual Pharma recalls 216,766 bottles that may have chemical leaching labels. More | Follow @EricPFierce

@CarlyHFierce: UPDATED: Sorry, Celgene, patent board says. Bass can challenge your IP, and profit, too. Article | Follow @CarlyHFierce

> Allergan cuts H2 sales forecast, but 10% growth on tap for 2016. Article

> Pfizer CEO sees no real future for Clinton's drug-pricing proposals. Item

Drug Delivery News

> MedImmune licenses 3M compound in hopes of developing intratumorally injected cancer drug. Article

> Bayer introduces autoinjector for its multiple sclerosis drug to counter looming generics. Report

> Surefire Medical launches cancer drug delivery catheter. Item

> Molecular 'wrench' gives delivery machinery an edge. Story

> Intarcia buys Phoundry in search of additional diabetes drugs for its subdermal drug pump. Article

Pharma Manufacturing News

> Genovate Biotechnology of Taiwan building $55M insulin plant in China. More

> Jaguar inks deal with Glenmark to produce animal diarrhea drugs. Report

> Manufacturers' association says pharma contract manufacturing in India growing at 20%. Item

> Novartis issues voluntary recall of ADHD drug manufactured in Georgia. Story

> Manufacturing issues result in another blow to Sun Pharma from FDA. Article

Pharma Asia News

> Apotex recalls cevimeline hydrochloride drugs made in India as FDA notes stability issues. Report

> Bill Gates exhorts China healthcare innovators to do good, and well. More

> Indonesia seen spending 18% more on pharmaceuticals in 2015. Item

> AbbVie wins Viekirax nod in Japan as expected with competition seen tight. Story

> India's Sun Pharma research arm sees FDA nod for Elepsia XR yanked by FDA on manufacturing. Article

Suggested Articles

In this week's EuroBiotech Report, Sanofi cuts staff in R&D rejig, AstraZeneca bets on Korea and uniQure weighs buyout bids.

In our EuroBiotech roundup this week, BioNTech and Genmab start cancer trial, Oncopeptides posts cancer data and F-star hires CFO.

Chief Operating Officer Dan Paterson will lead the company while it looks for a permanent successor with commercial chops.